So if you're lucky enough to be born in a rich country, your risk of death in that first year of life is about half a percent. And current 10 year olds have this incredible title. They've got a less than one in 10,000 chance of not making their 11th birthday. So I'm 40 this year, and that means my risk of death is about 1 in 1,000. By the time I'm 65, it away about 1%. By the time I'm 80, it's about 5%, so that's 1 in 20 per year. And if we're lucky enough to live into our 90s, but unlucky enough that none of the science we're going to talk about today has come to pass, you're going to have a risk of death of about 1 in 6. But what I've come to believe is that actually biology has many of the same questions. They're not fundamental particles or the depths of deep space. But the fact is that our

bodies are made up of somewhere between 30 and 40 trillion cells. And this is the science of complexity.

The questions there are just as deep and just as fascinating, but they also have a huge potential

to, you know, make people healthier. And if we can do gene therapies for longevity, which are

a potential thing, you know, we've discovered a gene in an Amish population in the US that makes people live 10 years longer.

We have loads of genes in animals that provide, you know, comparably exciting changes in lifespan.

Would I bet against there being a longevity gene therapy in the next 10 or 20 years?

I probably wouldn't because the technology is advancing so fast.

To paraphrase the great Charles Darwin, species endure not by brute strength or vast

intelligence, but by their capacity to adapt to shifting circumstances.

As Mike Milken said on this podcast, the greatest achievement of humankind in the 20th century

was the doubling of life expectancy. So if living longer

seems a powerful goal, my caveat would be only if it goes hand in hand with being healthy,

whilst being older, and in not running out of money. So to bring his petri dish, skullple,

and stethoscope to this subject, we're delighted to welcome day Dr Andrew Steele,

lecturer, author and speaker and expert on the topic of aging, as we all think about the health

and financial implications of what may lie ahead. So Andrew, over from Berlin today, welcome to the

Money Maids podcast. Thank you very much for having me. Well, we had the pleasure of listening to you on this topic at the Money Maes Allocator Summit

in October, ahead of the panel called Golden Dawn in Healthcare, where you created a palpable

sense of amazement, curiosity and hope. Oh, thank you. And I'd like to dissect this conversation

into four parts.

Examination, diagnosis, treatment and side effects.

...